Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Daniel Jacob Becker"'
Autor:
Chengwei Peng, Saad Saffo, Michael Shusterman, Daniel Jacob Becker, Jordan Berlin, Paul Eliezer Oberstein, Anil Nagar, Shun Yu
Publikováno v:
Journal of Clinical Oncology. 41:59-59
59 Background: 5-Fluorouracil (5-FU) is a component of first-line treatment regimens for metastatic colorectal cancer (mCRC). Historically, 5-FU is administered as a bolus followed by an infusion. However, the bolus dose adds substantial toxicity and
Autor:
Kenneth Csehak, Alexander Michael Barbaro, Stefanie D. Roman, Scott Sherman, Danil V. Makarov, Sahnah Lim, Daniel Jacob Becker
Publikováno v:
Journal of Clinical Oncology. 40:11059-11059
11059 Background: As the largest integrated healthcare system in the US, the Veterans Health Administration (VHA) is chartered “to serve as the primary backup for any health care services needed...in the event of war or national emergency” accord
Autor:
Sarah G Poland, Hannah Maynard, James Hart Stoeckle, Stefanie D. Roman, Scott Sherman, Daniel Mettman, Danil V. Makarov, Daniel Jacob Becker
Publikováno v:
Journal of Clinical Oncology. 40:e18617-e18617
e18617 Background: Precision oncology, targeting therapy to the molecular specifics of one patient’s cancer, improves outcomes and decreases toxicity. Previous studies have documented underuse of next generation sequencing (NGS) in both the Veteran
Publikováno v:
Journal of Clinical Oncology. 36:e18752-e18752
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 90:S44
Publikováno v:
Journal of Clinical Oncology. 32:e17659-e17659
e17659 Background: Development of the EGFR tyrosine kinase inhibitors (TKI’s) and FDA approval of erlotinib in 2004 began a decade of advances in targeted therapy for advanced lung cancer. Lung ade...
Autor:
Lynn Goldstein, Mimi Y. Kim, Abraham Chachoua, Bilal Piperdi, Daniel Jacob Becker, Jorge Gomez, Roman Perez-Soler, Michael L. Grossbard, Benjamin Levy
Publikováno v:
Journal of Clinical Oncology. 32:TPS8132-TPS8132
TPS8132 Background: Metformin (MTF), an oral biguanide, has recently demonstrated preventative and therapeutic effects in both preclinical and observational clinical studies in non-small cell lung ...
Autor:
Chandana Kakani, Michael L. Grossbard, Ilan Shapira, Daniel Jacob Becker, Ashwin Shreekant Sawant, Mark Floyd, Rangaswamy Chintapatla
Publikováno v:
Journal of Clinical Oncology. 32:8558-8558
8558 Background: The optimal surveillance imaging in the management of patients (pts) with non-Hodgkins lymphoma (NHL) remains undefined. Unnecessary scans increase health care costs and radiation ...
Publikováno v:
Journal of Clinical Oncology. 31:6571-6571
6571 Background: The optimal use and sequence of radiation therapy (RT), chemotherapy, and surgery for patients with stage III non-small cell lung cancer (NSCLC) is unknown. We conducted a cross-sectional study using the Surveillance Epidemiology and
Autor:
Molly Thorn, Michael L. Grossbard, Peter Kozuch, Janna Roitman, Daniel Jacob Becker, Mina Samir Erian Hanna
Publikováno v:
Journal of Clinical Oncology. 31:e17566-e17566
e17566 Background: Shortages of intravenous leucovorin were initially reported in late 2008, and availability plummeted nationally and at Continuum Cancer Centers of New York (CCCNY) in late 2011. NCCN guidelines recommend either the use of levoleuco